Abstract
Fluorimetric methods to assess cytochrome P450 (P450) activities that do not require metabolite separation have been developed. These methods make use of non- or low-fluorescent P450 substrates that produce highly fluorescent metabolites in aqueous solutions. The assays are based on the direct incubation of intact cells in culture with appropriate fluorogenic probe substrates, followed by fluorimetric quantification of the product formed and released into incubation medium. We describe a battery of fluorescence assays for rapid measurement of the activity of nine P450s involved in drug metabolism. For each individual P450 activity the probe showing the best properties (highest metabolic rates, lowest background fluorescence) has been selected. Fluorescence-based assays are highly sensitive and allow the simultaneous activity assessments of cells cultured in 96-well plates, using plate readers, with notable reductions in costs, time, and cells, thus enhancing sample throughput.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cytochrome P450 home page (http://drnelson.utmem.edu/CytochromeP450.html)
Hewitt NJ, Gomez-Lechón MJ, Houston JB et al (2007) Primary hepatocytes: Current understanding of the regulation of metabolic enzymes, transporter proteins and how they are used in pharmaceutical practice. Drug Metab Rev 39:159–234
Lahoz A, Donato MT, Castell JV, Gómez-Lechón MJ (2008) Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry. Curr Drug Metab 9:12–19
Donato MT, Jiménez N, Castell JV, Gómez-Lechón MJ (2004) Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos 32:699–706.5
Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT (1995) Ethoxy-, pentoxy-, and benzyloxyphenoxasones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337–3345
Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL (2002) Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos 30:845–852
White INH (1988) A continuous fluorimetric assay for cytochrome P-450-dependent mixed function oxidases using 3-cyano-7-ethoxycoumarin. Anal Biochem 172:304–310
Venhorst J, Onderwater RCA, Meerman JHN, Vermeulen NPE, Commandeur JNM (2000) Evaluation of a novel high-throughput assay for cytochrome P450 2D6 using 7-methoxy-4-(aminophenyl)-coumarin. Eur J Pharmaceut Sci 12:151–158
Chauret N, Dobss B, Lackman RL, Bateman K, Nicoll-Griffith DA, Stresser DM, Ackermann JM, Turner SD, Miller V, Crespi CL (2001) The use of 3-[2-N, N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes. Drug Metab Dispos 29:1196–1200
Chauret N, Tremblay N, Lackman RL, Gauthier JY, Silva JM, Marois J, Yergey JA, Nicoll-Griffith DA (1999) Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Anal Biochem 276:215–226
Nerurkar PV, Park SS, Thomas PE, Nims RW, Lubet RA (1993) Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46:933–943
Soars MG, Mcginnity DF, Grime K, Riley RJ (2007) The pivotal role of hepatocytes in drug discovery. Chem Biol Interact 168:2–15
Gómez-Lechón MJ, Castell JV, Donato MT (2008) An update on metabolism studies using human hepatocytes in primary culture. Expert Opin Drug Metab Toxicol 4:837–854
Gómez-Lechón MJ, Lahoz A, Gombau L, Castell JV, Donato MT (2010) In vitro evaluation of potential hepatotoxicity induced by new drugs. Curr Pharm Design 16:1963–1977
Gómez-Lechón MJ, Donato MT, Castell JV, Jover R (2004) Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab 5:443–462
Donato MT, Lahoz A, Castell JV, Gómez-Lechón MJ (2008) Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 9:1–11
Pfeifer AMA, Cole KE, Smoot DT, Weston A, Groopman JD, Shields PG, Vignaud JM, Juillerat A, Lipsky MM, Trump BF, Lechner JF, Harris CC (1993) Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolise chemical carcinogens. Proc Natl Acad Sci 90:5123–5127
Bort R, Castell JV, Pfeifer A, Gómez-Lechón MJ, Macé K (1999) High expression of human CYP2C in immortalized human liver epithelial cells. Toxicol In Vitro 13:633–638
Donato MT, Castell JV (2003) Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin Pharmacokinet 42:153–178
Donato MT, Gómez-Lechón MJ, Castell JV (1993) A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Biochem 213:29–33
Lahoz A, Gombau L, Donato MT, Castell JV, Gómez-Lechón MJ (2006) In vitro ADME medium/high-throughput screening in drug preclinical development. Mini Rev Med Chem 6:1053–1062
Di Marco A, Yao D, Laufer R (2003) Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes. Eur J Biochem 270:376837–376877
Xu L, Chen Y, Pan Y, Skiles GL, Shou M (2009) Prediction of human drug-drug interactions from time-dependent inactivation of CYP3A4 in primary hepatocytes using a population-based simulator. Drug Metab Dispos 37:2330–2339
Guidance for industry: drug interaction studies—study design, data analysis, and implications for dosing and labelling. Guidance draft, 2006. Available at: www.fda.gov/cber/gdlns/interactstud.htm
Hewitt NJ, de Kanter R, LeCluyse E (2007) Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry—do they comply with FDA recommendations? Chem Biol Interact 168:51–65
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Donato, M.T., Gómez-Lechón, M.J. (2013). Fluorescence-Based Screening of Cytochrome P450 Activities in Intact Cells. In: Phillips, I., Shephard, E., Ortiz de Montellano, P. (eds) Cytochrome P450 Protocols. Methods in Molecular Biology, vol 987. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-321-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-62703-321-3_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-320-6
Online ISBN: 978-1-62703-321-3
eBook Packages: Springer Protocols